Frontlight ResearchEarly access
Trial site
Kawartha Cardiology Clinical Trials
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Heart failure6 trials
- Obesity4 trials
- Type 2 diabetes3 trials
- Chronic kidney disease2 trials
- Coronary artery disease2 trials
- Stroke2 trials
- Atrial fibrillation1 trial
- High blood pressure1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 314 trials
- Status
- Completed8 trials
- Recruiting4 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S5 trials
- Boehringer Ingelheim3 trials
- Amgen2 trials
- Eli Lilly and Company2 trials
- Janssen Research & Development, LLC2 trials
- and 1 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure4 recruiting
- Obesity3 recruiting
- High blood pressure1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026